Breast implant study to see how Luna implants perform after surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, non-comparative study tracking the durability of Eurosilicone Luna mammary implants over a 10-year period. It aims to measure the frequency of implant rupture and Baker III-IV capsular contracture in women undergoing primary or revision augmentation or reconstruction. Participants will be female between 18 and 65 years old who receive the Luna implants and agree to long-term follow-up. Data will be collected from surgical procedures and follow-up visits to assess implant performance and safety. No randomized or comparative interventions are performed beyond standard surgical care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* The target population includes subjects undergoing augmentation or reconstructive breast implant surgery in which the Eurosilicone Luna mammary implant is recommended.

Inclusion criteria are:

1. Genetic female subjects aged between 18 and 65 years old.
2. Subjects who underwent single or bilateral breast implantation with the study device for one of the following reasons:

i. Primary breast reconstruction following mastectomy (both for one-stage or two-stage surgeries, including patients with previous radiotherapy and who have ADMs (synthetic or natural).

ii. Primary breast augmentation (cosmetic surgery) with or without mastopexy iii. Breast revision surgery with or without mastopexy c) Subjects who have received a Eurosilicone Luna implant. d) Subjects who have provided informed consent and can adhere to the requirements of follow-up appointments as per the study protocol.

Exclusion criteria are:

1. Subjects with a BMI \>35.
2. Subjects with autoimmune disease, lung fibrocystic disease, conditions that interfere with wound healing and blood clotting, a weakened immune system, reduced blood supply to the breast tissue or any other condition for which breast implants are contraindicated.
3. Subjects who have participated in a clinical study which involve chemical or drug study within 3 months prior to surgery, with the exception of subjects who are participating in breast cancer-related clinical studies.
4. Subjects with insufficient tissue covering due to either radiation damage on the chest wall, tight thoracic skin grafts or radical resection of the pectoralis major muscle.
5. Subjects who, in the Investigator's clinical opinion, have existing local or metastatic carcinoma of the breast that is unlikely to be fully excised at the time of insertion of the breast implant.
6. Subjects with known previous history of a sensitivity to silicone who, in the opinion of the Investigator, are unsuitable for surgery.
7. Subjects with an active infection who are unsuitable for surgery unless, in the opinion of the investigator, they are treated and cleared by the investigator.
8. Subjects with a history of abscesses anywhere in the body who, in the opinion of the Investigator, are unsuitable for surgery.
9. Subjects with a known history of compromised wound healing.
10. Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study.
11. Women who are pregnant and/or current breast feeders who do not stop breast feeding within 3 months of getting breast implants.
12. Patients who have local recurrence or metastatic carcinoma at the time of insertion of breast implant.

Where it's running

• Dr Guillaume Lasserre
  Villefranche-sur-Saône, France Recruiting
• DScultp Clinic
  Barcelona, Spain Recruiting

Study contacts

• Study coordinator: GCA Clinical affairs department
• Email: luna10PMCF@gcaesthetics.com
• Phone: +33 783326098

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-term follow-up of Nagor Perle smooth gel mammary implants

  This project will follow adults who receive Nagor Perle smooth gel breast implants to see if they stay safe and work well over 10 years.

  Recruiting GCA (Eurosilicone) · Manchester · NCT06013514

• ESP Blocks to Help Pain After Breast Reconstruction with Autologous Flaps

  This study tests whether erector spinae plane blocks can improve pain control after autologous free flap breast reconstruction in adults.

  Recruiting Phase 1 Carilion Clinic · Roanoke, Virginia · NCT07891039

• Improved Breast Enlargement Using Your Own Fat Tissue

  This study tests a temporary device to help your own fat grafting for breast enlargement stay in place and keep volume after surgery.

  Recruiting 4Tissue · Edegem and 1 other locations · NCT07869641

• EndoBreast: Feasibility and outcomes of nipple-sparing endoscopic mastectomy with immediate reconstruction

  This observational study tests whether endoscopic nipple-sparing mastectomy with immediate reconstruction is feasible and acceptable for women at risk or with breast cancer.

  Recruiting Azienda Sanitaria Locale Biella · Ponderano, BI · NCT07718425

• Access My Breast Cancer Care App

  A breast cancer care app is being tested to see if it helps patients navigate care, feel more satisfied, and reduce in-person visits.

  Recruiting at 2 sites University of British Columbia · Vancouver, British Columbia and 1 other locations · NCT07696637

• Autologous Fat Grafting vs DIEP flap for reconstructed breast after radiation

  This study tests whether autologous fat transfer can provide similar satisfaction and safety to the DIEP flap procedure for women needing breast reconstruction after mastectomy and radiation.

  Recruiting Maastricht University Medical Center · Maastricht, Limburg · NCT07641985

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.